Thrombocytosis.

@article{Skoda2009Thrombocytosis,
  title={Thrombocytosis.},
  author={Radek C. Skoda},
  journal={Hematology. American Society of Hematology. Education Program},
  year={2009},
  pages={159-67}
}
Major progress in understanding the pathogenesis in patients with thrombocytosis has been made by identifying mutations in the key regulators of thrombopoietin: the thrombopoietin receptor MPL and JAK2. Together, these mutations can be found in 50% to 60% of patients with essential thrombocythemia or primary myelofibrosis and in 10% to 20% of hereditary… CONTINUE READING